CN103393946A - Drug for treating type-2 diabetes - Google Patents
Drug for treating type-2 diabetes Download PDFInfo
- Publication number
- CN103393946A CN103393946A CN2013103385001A CN201310338500A CN103393946A CN 103393946 A CN103393946 A CN 103393946A CN 2013103385001 A CN2013103385001 A CN 2013103385001A CN 201310338500 A CN201310338500 A CN 201310338500A CN 103393946 A CN103393946 A CN 103393946A
- Authority
- CN
- China
- Prior art keywords
- parts
- fructus
- rhizoma
- bletillae
- schisandrae chinensis
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Landscapes
- Medicines Containing Plant Substances (AREA)
Abstract
The invention provides a drug for treating type-2 diabetes. The drug comprises, by weight, 3-8 parts of gypsum, 4-10 parts of balsam pear, 6-12 parts of Chinese yam, 10-15 parts of root of kudzu vine, 8-12 parts of radix astragali, 6-18 parts of mulberry, 8-16 parts of polygonatum rhizome, 4-12 parts of Chinese magnoliavine, 15-25 parts of bletilla striata and 10-15 parts of wolfberry. The drug has the advantages of good treatment effects and small side effects.
Description
Technical field
The present invention relates to a kind of Chinese medicine, particularly a kind of medicine for the treatment of type 2 diabetes mellitus.
Background technology
Type 2 diabetes mellitus typically refers to endocrine regulation, make the regulatory function of insulin not normal and then cause in blood and a kind of disease that in urine, sugar content increases, it is a kind of chronic, multiple commonly encountered diseases, how with complication, and sickness rate has the trend that increases year by year, and it and cancer, cardiovascular disease are regarded as worldwide three large diseases.Nearly recent decades, the various countries researcher has carried out a large amount of research and development to the treatment of diabetes, but these achievements all concentrate on and control the glycosuria rising, glucose in urine raises the stage, and the long-term taking Western medicine is larger on the impact of metabolism and organ injury, mostly exist certain side effect, effect is not fully up to expectations, and is not good to the control of diabetes.
Summary of the invention
The objective of the invention is to overcome therapeutic effect not obvious, the deficiency that side effect is large, provide a kind of medicine for the treatment of type 2 diabetes mellitus.
Technical scheme of the present invention is:
A kind of medicine for the treatment of type 2 diabetes mellitus comprises: Gypsum Fibrosum, Fructus Momordicae charantiae, Rhizoma Dioscoreae, Radix Puerariae, the Radix Astragali, Fructus Mori, Rhizoma Polygonati, Fructus Schisandrae Chinensis, the Pseudobulbus Bletillae (Rhizoma Bletillae), Fructus Lycii, and wherein the ratio of weight and number of each component is:
Gypsum Fibrosum 3-8 part
Fructus Momordicae charantiae 4-10 part
Rhizoma Dioscoreae 6-12 part
Radix Puerariae 10-15 part
Radix Astragali 8-12 part
Fructus Mori 6-18 part
Rhizoma Polygonati 8-16 part
Fructus Schisandrae Chinensis 4-12 part
Pseudobulbus Bletillae (Rhizoma Bletillae) 15-25 part
Fructus Lycii 10-15 part
Preferably, the ratio of weight and number of above-mentioned raw materials is:
Gypsum Fibrosum 3-7 part
Fructus Momordicae charantiae 4-9 part
Rhizoma Dioscoreae 6-10 part
Radix Puerariae 10-14 part
Radix Astragali 8-11 part
Fructus Mori 6-15 part
Rhizoma Polygonati 8-14 part
Fructus Schisandrae Chinensis 4-10 part
Pseudobulbus Bletillae (Rhizoma Bletillae) 15-20 part
Fructus Lycii 10-13 part
Preferably, the ratio of weight and number of above-mentioned raw materials is:
4 parts, Gypsum Fibrosum
6 parts, Fructus Momordicae charantiae
8 parts of Rhizoma Dioscoreaes
12 parts of Radix Puerariaes
10 parts of the Radixs Astragali
10 parts of Fructus Mori
14 parts of Rhizoma Polygonatis
8 parts of Fructus Schisandrae Chinensis
17 parts of the Pseudobulbus Bletillae (Rhizoma Bletillae)s
12 parts of Fructus Lycii
The advantage that the present invention has and good effect are that good effect, side effect are little.
The specific embodiment
The invention will be further described below in conjunction with specific embodiment, but do not limit the present invention.
Embodiment 1
A kind of medicine for the treatment of type 2 diabetes mellitus comprises: Gypsum Fibrosum, Fructus Momordicae charantiae, Rhizoma Dioscoreae, Radix Puerariae, the Radix Astragali, Fructus Mori, Rhizoma Polygonati, Fructus Schisandrae Chinensis, the Pseudobulbus Bletillae (Rhizoma Bletillae), Fructus Lycii, and wherein the ratio of weight and number of each component is:
4 parts, Gypsum Fibrosum
6 parts, Fructus Momordicae charantiae
8 parts of Rhizoma Dioscoreaes
12 parts of Radix Puerariaes
10 parts of the Radixs Astragali
10 parts of Fructus Mori
14 parts of Rhizoma Polygonatis
8 parts of Fructus Schisandrae Chinensis
17 parts of the Pseudobulbus Bletillae (Rhizoma Bletillae)s
12 parts of Fructus Lycii
Embodiment 2
A kind of medicine for the treatment of type 2 diabetes mellitus comprises: Gypsum Fibrosum, Fructus Momordicae charantiae, Rhizoma Dioscoreae, Radix Puerariae, the Radix Astragali, Fructus Mori, Rhizoma Polygonati, Fructus Schisandrae Chinensis, the Pseudobulbus Bletillae (Rhizoma Bletillae), Fructus Lycii, and wherein the ratio of weight and number of each component is:
6 parts, Gypsum Fibrosum
8 parts, Fructus Momordicae charantiae
9 parts of Rhizoma Dioscoreaes
12 parts of Radix Puerariaes
9 parts of the Radixs Astragali
10 parts of Fructus Mori
9 parts of Rhizoma Polygonatis
7 parts of Fructus Schisandrae Chinensis
18 parts of the Pseudobulbus Bletillae (Rhizoma Bletillae)s
12 parts of Fructus Lycii
The above, be only preferred embodiment of the present invention, not technical scheme of the present invention done any pro forma restriction.Every foundation technical spirit of the present invention, to any simple modification, equivalent variations and modification that above embodiment does, all still belongs in the scope of technical scheme of the present invention.
Claims (3)
1. medicine for the treatment of type 2 diabetes mellitus is characterized in that: comprising: Gypsum Fibrosum, Fructus Momordicae charantiae, Rhizoma Dioscoreae, Radix Puerariae, the Radix Astragali, Fructus Mori, Rhizoma Polygonati, Fructus Schisandrae Chinensis, the Pseudobulbus Bletillae (Rhizoma Bletillae), Fructus Lycii, and wherein the ratio of weight and number of each component is:
Gypsum Fibrosum 3-8 part
Fructus Momordicae charantiae 4-10 part
Rhizoma Dioscoreae 6-12 part
Radix Puerariae 10-15 part
Radix Astragali 8-12 part
Fructus Mori 6-18 part
Rhizoma Polygonati 8-16 part
Fructus Schisandrae Chinensis 4-12 part
Pseudobulbus Bletillae (Rhizoma Bletillae) 15-25 part
Fructus Lycii 10-15 part.
2. a kind of medicine for the treatment of type 2 diabetes mellitus according to claim 1, it is characterized in that: the ratio of weight and number of above-mentioned raw materials is:
Gypsum Fibrosum 3-7 part
Fructus Momordicae charantiae 4-9 part
Rhizoma Dioscoreae 6-10 part
Radix Puerariae 10-14 part
Radix Astragali 8-11 part
Fructus Mori 6-15 part
Rhizoma Polygonati 8-14 part
Fructus Schisandrae Chinensis 4-10 part
Pseudobulbus Bletillae (Rhizoma Bletillae) 15-20 part
Fructus Lycii 10-13 part.
3. a kind of medicine for the treatment of type 2 diabetes mellitus according to claim 1 and 2, it is characterized in that: the ratio of weight and number of above-mentioned raw materials is:
4 parts, Gypsum Fibrosum
6 parts, Fructus Momordicae charantiae
8 parts of Rhizoma Dioscoreaes
12 parts of Radix Puerariaes
10 parts of the Radixs Astragali
10 parts of Fructus Mori
14 parts of Rhizoma Polygonatis
8 parts of Fructus Schisandrae Chinensis
17 parts of the Pseudobulbus Bletillae (Rhizoma Bletillae)s
12 parts of Fructus Lycii.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN2013103385001A CN103393946A (en) | 2013-08-06 | 2013-08-06 | Drug for treating type-2 diabetes |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN2013103385001A CN103393946A (en) | 2013-08-06 | 2013-08-06 | Drug for treating type-2 diabetes |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN103393946A true CN103393946A (en) | 2013-11-20 |
Family
ID=49557799
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN2013103385001A Pending CN103393946A (en) | 2013-08-06 | 2013-08-06 | Drug for treating type-2 diabetes |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN103393946A (en) |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN103735843A (en) * | 2014-01-29 | 2014-04-23 | 唐树青 | Medicine composition for treating diabetes |
Citations (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1403135A (en) * | 2002-09-29 | 2003-03-19 | 唐桂德 | Medicine for treating diabetes and its complication |
| CN1772225A (en) * | 2005-10-26 | 2006-05-17 | 钱南萍 | Recipe and prepn process of hypoglycemic Chinese medicine |
| CN101406627A (en) * | 2008-11-18 | 2009-04-15 | 乔国强 | Chinese medicine powder for treating diabetic |
| CN101708295A (en) * | 2009-12-04 | 2010-05-19 | 卢速江 | Chinese medicinal preparation for treating diabetes and preparation methods thereof |
-
2013
- 2013-08-06 CN CN2013103385001A patent/CN103393946A/en active Pending
Patent Citations (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1403135A (en) * | 2002-09-29 | 2003-03-19 | 唐桂德 | Medicine for treating diabetes and its complication |
| CN1772225A (en) * | 2005-10-26 | 2006-05-17 | 钱南萍 | Recipe and prepn process of hypoglycemic Chinese medicine |
| CN101406627A (en) * | 2008-11-18 | 2009-04-15 | 乔国强 | Chinese medicine powder for treating diabetic |
| CN101708295A (en) * | 2009-12-04 | 2010-05-19 | 卢速江 | Chinese medicinal preparation for treating diabetes and preparation methods thereof |
Non-Patent Citations (1)
| Title |
|---|
| 盛清凯等: "苦瓜降糖多肽-P对2型糖尿病模型鼠血糖血脂的影响", 《山东农业大学学报（自然科学版）》 * |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN103735843A (en) * | 2014-01-29 | 2014-04-23 | 唐树青 | Medicine composition for treating diabetes |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN101524471A (en) | Pharmaceutical composition for treating diabetes and preparation method thereof | |
| CN103623248B (en) | Traditional Chinese medicinal composition for reducing blood pressure | |
| CN102048946A (en) | Traditional Chinese medicine formula for treating insomnia | |
| CN103055198A (en) | Medicine for treating diabetes mellitus and preparation method thereof | |
| CN101167893A (en) | Traditional Chinese medicine for treating viral hepatitis | |
| CN103393946A (en) | Drug for treating type-2 diabetes | |
| CN103550414A (en) | Traditional Chinese medicine formula for treatment of prostatitis | |
| CN101129967A (en) | Traditional Chinese medicine for treating diabetic diarrhea | |
| CN102940782B (en) | Chinese medicinal composition for reducing blood sugar | |
| CN102370954A (en) | Medicine for treating chronic rhinitis | |
| CN101732478A (en) | Chinese medicament for treating constipation | |
| CN101856448A (en) | Chinese medicament for treating diabetes mellitus | |
| CN104740469A (en) | Traditional Chinese medicine prescription for treating diabetes | |
| CN101612251B (en) | Traditional Chinese medicine for treating primary liver cancer | |
| CN103566186A (en) | Medicament for treating diabetes | |
| CN102908544B (en) | Traditional Chinese medicine decoction for treating coronary disease and preparation method thereof | |
| CN103349762B (en) | Traditional Chinese medicine used for treating type II diabetes | |
| CN103386031A (en) | Drug for treating vascular dementia | |
| CN102125653A (en) | Anti-inflammatory antitussive medicine | |
| CN202751610U (en) | Diffused particle for treating diabetes | |
| CN103816408A (en) | Traditional Chinese medicine for diabetes | |
| CN106581402A (en) | Traditional Chinese medicine for treating high blood pressure | |
| CN103830596A (en) | Traditional Chinese medicine for treating diabetes mellitus | |
| CN102698055B (en) | Traditional Chinese medicine for treating cold and preparation method of traditional Chinese medicine | |
| CN104706736A (en) | Chinese patent medicine Qiangxin Kang capsule for treating chronic heart failure and preparation method thereof |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| C02 | Deemed withdrawal of patent application after publication (patent law 2001) | ||
| WD01 | Invention patent application deemed withdrawn after publication |
Application publication date: 20131120 |